Thomas Steyer’s Globus Medical GMED Stock Holding History

Thomas Steyer’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,000	Closed	-$345K	–	128
2026 Q1	$345K	Hold	4,000	–	–	﹤0.01%	114
2025 Q4	$349K	Hold	4,000	–	–	﹤0.01%	103
2025 Q3	$229K	Sell	4,000 -206,000	-98%	-$11.9M	﹤0.01%	115
2025 Q2	$12.4M	Buy	210,000 +127,000	+153%	+$8.21M	0.05%	79
2025 Q1	$6.08M	Buy	83,000 +79,400	+2,206%	+$6.56M	0.03%	79
2024 Q4	$298K	Hold	3,600	–	–	﹤0.01%	114
2024 Q3	$258K	Hold	3,600	–	–	﹤0.01%	125
2024 Q2	$247K	Buy	+3,600	New	+$215K	﹤0.01%	124

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Thomas Steyer's GMED Position: Q2 2026 in Review

Thomas Steyer sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 4,000 shares — an estimated $345K sold.

Thomas Steyer first reported a position in GMED in Q2 2024 and held it in 8 quarters. The position peaked at $12.4M in Q2 2025. 593 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Thomas Steyer reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
Thomas Steyer sold 4,000 Globus Medical shares in Q2 2026, an estimated $345K.
Thomas Steyer first reported a position in Globus Medical in Q2 2024 and held it in 8 quarters.
Thomas Steyer's Globus Medical position peaked at $12.4M in Q2 2025.
593 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.